Results 211 to 220 of about 24,574 (253)

Efficacy, safety, and effect on platelet activation of the timing of administration of tirofiban in patients with acute ischemic stroke. [PDF]

Am J Transl Res
Wang M, Zhang F, Guo Q, Wang W, Wu K, Chen H.   +5 more
europepmc   +1 more source

Platelet-Activating Factor (PAF) Induces Strong Mechanical Activities Accompanied by Basal Tension Increases in Esophageal and Gastric Fundus Smooth Muscles from Rat

Keisuke Obara, Satoru Takahashi, Miho Otake, Mako Fujiwara, Mio Yamashita, Azusa Murata, Kento Yoshioka, Yoshio Tanaka   +7 more
openalex   +2 more sources

The crystal structure of 1 (3,4-dimethoxyphenyl) – 2 -(thiophenoxy) - 1-propanone, a platelet activating factor (paf-acether) antagonist

, 1995
C. Lariucci, L.I.B. Homar, Pedro Henrique Ferri, Lourivaldo da Silva Santos   +3 more
openalex   +1 more source

Clinical Values of Serum Platelet-Activating Factor in Hypertensive Disorders Complicating Pregnancy.

Kidney Blood Press Res
Liu S, Lan Q, Li W, Zhang J, Fu L, Xu Y, Li Y.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet-Activating Factor Acetylhydrolase (PAF-AH)

Journal of Biochemistry, 2002
Platelet-activating factor (PAF) is one of the most potent lipid messengers involved in a variety of physiological events. The acetyl group at the sn-2 position of its glycerol backbone is essential for its biological activity, and its deacetylation induces loss of activity. The deacetylation reaction is catalyzed by PAF-acetylhydrolase (PAF-AH).
Hiroyuki, Arai, Hiroyuki, Koizumi, Junken, Aoki, Keizo, Inoue   +3 more
openaire   +2 more sources

Platelet activating factor (PAF) and lyso-PAF in psoriasis

Archives of Dermatological Research, 1994
Previous studies have shown that scale from lesional psoriatic skin contains substantial amounts of platelet activating factor (PAF). In this study, PAF and its immediate precursor, lyso-PAF, were measured in exudates from abrasions on lesional and uninvolved psoriatic skin, and from skin of healthy subjects.
M R, Judge, R M, Barr, A I, Mallet, F, Courtney, A, Kobza Black, M W, Greaves   +5 more
openaire   +2 more sources

Platelet Activating Factor (PAF): A Mediator of Inflammation

BioFactors, 2022
AbstractPlatelet‐activating factor (PAF) is a phospholipid‐derived mediator with an established role in multiple inflammatory states. PAF is synthesized and secreted by multiple cell types and is then rapidly hydrolyzed and degraded to an inactive metabolite, lyso‐PAF, by the enzyme PAF acetylhydrolase.
Julia E. M. Upton, Eyal Grunebaum, Gordon Sussman, Peter Vadas   +3 more
openaire   +2 more sources

Procoagulant property of platelet activating factor (PAF)

Agents and Actions, 1993
Platelet-activating factor (PAF) is known to activate platelets and thus promote clot formation in most mammalian species including humans. In this communication, the ability of PAF to hasten the overall coagulation process by measuring the recalcification time (RT) is described.
G W, Raff, C R, Spillert, D J, Wilson, E J, Lazaro   +3 more
openaire   +2 more sources

Plasma platelet activating factor-acetylhydrolase (PAF-AH)

Progress in Lipid Research, 2003
The platelet-activating factor-acetylhydrolase (PAF-AH) is an enzyme which catalyzes the hydrolysis of acetyl ester at the sn-2 position of PAF. The family of PAF-AHs consists of two intracellular isoforms (Ib and II), and one secreted isoform (plasma). These PAF-AHs show different biochemical characteristics and molecular structures. Plasma PAF-AH and
Ken, Karasawa, Ayako, Harada, Noriko, Satoh, Keizo, Inoue, Morio, Setaka   +4 more
openaire   +2 more sources